Durvalumab
CAS: 1428935-60-7
Ref. 3D-DHC93560
1mg | A consultar | |
5mg | A consultar | |
10mg | A consultar | |
25mg | A consultar |
Información del producto
Durvalumab is a human immunoglobulin G1 (IgG1) monoclonal antibody that binds to PD-L1, a protein expressed on the surface of tumor cells. Durvalumab is being studied in combination with tremelimumab (another anti-PD-L1 antibody) for use as an antitumor agent. The combination of durvalumab and tremelimumab has been shown to have an antitumor response in mice with bowel disease. This drug has been shown to have an immune-modulating effect in combination therapy groups.
Propiedades químicas
Consulta técnica sobre: 3D-DHC93560 Durvalumab
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.